US healthcare spending surpassed $4.5 trillion, yet only a fraction of digital health companies successfully secure value-based contracts with Medicare Advantage plans, ACOs, or risk-bearing providers.
The gap isn’t product quality.
It’s commercialization architecture.

Winning US value-based care (VBC) contracts is not about selling software. It’s about aligning with federal payers, coding infrastructure, risk entities, real-world evidence systems, and shared-savings models.

This is where most founders fail.

Below is a structured breakdown of the US Value-Based Care Stack—and the system required to convert innovation into reimbursable, risk-aligned revenue.

🧭 The 4-Step Framework: Risk-Aligned Commercialization

1️⃣ CPT / HCPCS Code Alignment

2️⃣ Medicare Advantage & ACO Partnership

3️⃣ Real-World Evidence & Outcomes Validation

4️⃣ Shared-Savings Contract Structuring

Miss one layer, and the contract collapses.

🏛 Category 1: Federal Payers

(The Incentive Architects of US Healthcare)

This layer defines the economic rules of the game.

At the top sits:

• Centers for Medicare & Medicaid Services (CMS)

• Center for Medicare & Medicaid Innovation (CMMI)

• Medicare

• Medicaid

These entities do not simply reimburse care — they define:

• Risk adjustment formulas

• Star rating bonus structures

• Quality reporting mandates

• Value-based model pilots

• Shared savings benchmarks

• Coding reimbursement frameworks

Every Medicare Advantage plan ultimately orbits CMS policy.

Then you have the national MA carriers and integrated giants:

• UnitedHealth Group

• Humana

• CVS Health (Aetna)

• Elevance Health

• Kaiser Permanente

• Blue Cross Blue Shield Association

• Cigna

• Centene

• Molina

• SCAN Health Plan

• Alignment Health

And vertically integrated provider platforms like:

• Oak Street Health

• ChenMed

• One Medical

These organizations operate under capitated payment structures. They are paid per member per month (PMPM), adjusted for risk.

Their profitability depends on:

• Managing total cost of care

• Improving star ratings

• Optimizing RAF (Risk Adjustment Factor)

• Preventing avoidable admissions

• Coordinating chronic disease management

Why This Layer Matters

If your solution does not tie directly into:

• Star rating improvement

• Risk score optimization

• Utilization reduction

• Quality measure improvement

• RAF documentation

Then it is not aligned with MA economics.

That means:

You are selling “innovation.”

They are buying “risk reduction.”

If you do not speak CMS incentive language, you are invisible to budget owners.

🏥 Category 2: Risk Providers

(The Economic Decision Makers)

This group includes:

• Aledade

• agilon health

• Privia Health

• VillageMD

• ApolloMed

• Clover Health

• Alignment Healthcare

• Somatus

• Cityblock Health

• DispatchHealth

• Monogram Health

• Pearl Health

• Upstream

• Wellvana

These are organizations that take financial risk for patient populations.

They participate in:

• MSSP

• ACO REACH

• MA delegated risk

• Bundled payment models

• Kidney care models

• Primary care capitation

Their mandate is simple:

Reduce Total Cost of Care (TCOC).

They evaluate vendors through a financial lens:

• Does this reduce admissions?

• Does this improve coding capture?

• Does this prevent downstream cost?

• Does this shorten length of stay?

• Does this reduce ED utilization?

They are not innovation buyers.
They are actuarial buyers.

Pain Point

Most startups present engagement data:

• Logins

• Satisfaction

• NPS

• Retention

Risk providers want:

• PMPM delta

• Risk score lift

• Claims trend shift

• Control vs intervention analysis

If you cannot quantify PMPM savings — you do not close.

Even if the product works clinically.

🧾 Category 3: Coding Bodies

(The Revenue Gatekeepers)

This layer determines whether your solution can legally and financially exist inside reimbursement frameworks.

Key institutions include:

• American Medical Association (CPT governance)

• National Uniform Billing Committee

• National Committee for Quality Assurance (HEDIS measures)

• Office of Inspector General

• Health Level Seven (HL7 standards)

• Office of the National Coordinator (ONC)

• American Academy of Professional Coders

• Healthcare Financial Management Association

These bodies define:

• CPT codes

• HCPCS codes

• Billing documentation standards

• Quality metrics

• Compliance obligations

• Interoperability requirements

Pain Point

Founders frequently assume:

“If we prove value, reimbursement will follow.”

But reimbursement is not emotional.

It is procedural.

If:

• There is no CPT pathway

• Documentation cannot justify billing

• Quality metrics do not capture your impact

• Interoperability standards are unmet

Then even a clinically valuable product cannot scale.

No CPT.
No revenue.
No compliance.
No contract.

📊 Category 4: Real-World Evidence (RWE) Platforms

(The Proof Engines)

This category includes:

• Komodo Health

• HealthVerity

• Flatiron Health

• Optum

• TriNetX

• Veradigm

• IQVIA

• Premier

• Clarify Health

• Evidation

• OMNY Health

• Tempus

• Datavant

• Redox

• Particle Health

• Health Catalyst

• Snowflake

• Palantir

These platforms aggregate:

• Claims data

• EHR data

• Lab results

• Longitudinal patient journeys

• Utilization trends

• Risk score histories

MA plans and ACOs increasingly require:

• Cohort analysis

• Risk-adjusted savings validation

• Comparative performance modeling

• Control vs intervention benchmarking

Pain Point

Clinical efficacy is no longer sufficient.

You must prove:

• Claims-based cost reduction

• Longitudinal PMPM savings

• Avoidable utilization decline

• RAF improvement

If your ROI lives only in internal dashboards — investors discount it.

If it lives in validated claims data — valuation expands.

🏥 Category 5: Care Platforms

(The Competitive Benchmark Layer)

These companies:

• Teladoc Health

• Amwell

• Included Health

• Sword Health

• Omada Health

• Virta Health

• Headspace Health

• Carbon Health

• Firefly Health

• K Health

• Oscar Health

• Evernorth

Represent the evolution of care delivery into risk-aware, digitally integrated models.

They illustrate:

• How virtual care can integrate into MA

• How chronic disease programs can tie to savings

• How employer and payer economics intersect

This layer matters because:

They set the benchmark.

Investors ask:

• Why will this beat Teladoc?

• Why will this beat Omada?

• What moat exists beyond engagement?

If you cannot articulate your risk-aligned edge relative to these platforms, funding conversations stall.

📈 Category 6: Risk Analytics

(The Actuarial Backbone)

Organizations like:

• Milliman

• Lumeris

• Evolent Health

• Cotiviti

• Apixio

• Guidehouse

• Zelis

• Change Healthcare

• Verisk

• NaviHealth

• R1 RCM

Operate at the intersection of:

• Risk adjustment

• Revenue cycle

• Claims auditing

• Actuarial modeling

• Quality measurement

• Capitated forecasting

These groups define whether savings claims are credible.

They translate:

Clinical performance → Financial viability.

Why This Layer Is Critical

When negotiating MA contracts, you are not debating features.

You are debating:

• Risk corridors

• Stop-loss thresholds

• Shared savings splits

• Attribution logic

• Actuarial confidence intervals

Without credible analytics backing your savings model:

• MA plans price conservatively

• Shared savings shrink

• Contracts delay

• Investors question scalability

The Strategic Synthesis: Why Most Founders Stall at Pilot Stage

These six categories are not separate ecosystems.

They are a single commercialization chain.

CMS Incentives
→ Risk Providers
→ Coding Governance
→ Claims Validation
→ Care Integration
→ Actuarial Structuring

Each layer feeds the next.

And if one breaks, contractability collapses.

What Most Founders Do

They build inside one layer:

🏥 Care Platform

They optimize UX.
They improve engagement.
They refine AI outputs.
They build dashboards.

But they never architect upstream and downstream.

They assume:

“If clinicians love it, contracts will follow.”

That assumption is fatal in value-based care.

Because MA plans are not buying technology.

They are buying:

• Risk reduction

• Financial predictability

• Cost containment

• Quality bonus leverage

If your product does not plug directly into that economic engine, it remains discretionary.

Why the Chain Matters for Conversion

Let’s walk through what actually happens when a startup closes a real MA contract.

Step 1: CMS Incentive Mapping

Your solution must map to:

• Star ratings

• HEDIS measures

• Risk score capture

• RAF optimization

• Cost benchmark improvement

If it does not align to federal incentive structures, the MA plan cannot justify scaling it.

Step 2: Risk Provider Economics

Now the risk-bearing provider asks:

• Does this reduce PMPM cost?

• Does it reduce admissions?

• Does it improve coding capture?

• Can we quantify savings by cohort?

If you cannot produce a financial model at this point, you stall.

Step 3: Coding Governance

The next filter:

• Is there CPT alignment?

• Is documentation sufficient?

• Does this create billing risk?

• Does it pass compliance review?

Even if savings are plausible, coding gaps kill contracts.

Step 4: Claims Validation

Now comes the actuarial lens.

MA plans do not trust:

• Engagement metrics

• Self-reported improvement

• Survey-based outcomes

They want:

• Claims-based validation

• Control vs intervention comparison

• Risk-adjusted cost curves

• Longitudinal evidence

If your ROI exists only in your internal analytics — your valuation compresses.

If it exists in validated claims data — investor confidence expands.

Step 5: Care Integration

Now the workflow question:

• Does it embed in EHR?

• Does it disrupt care teams?

• Does it require new headcount?

• Does it slow throughput?

Integration friction increases cost.

And anything that increases cost undermines your value story.

Step 6: Actuarial Structuring

Finally:

• What is the shared savings split?

• What is the risk corridor?

• Who absorbs downside?

• How is attribution handled?

This is where real MA contracts are won.

This is also where most startups fail — because they never prepared financially for this layer.

🚨 The Core Insight

Winning US value-based care is not about innovation.

It is about orchestration.

You are not selling a product.

You are selling a financial outcome inside a federally structured incentive system.

Most founders:

• Talk product

• Pitch features

• Avoid coding strategy

• Ignore MA plan economics

• Skip RWE validation

And then wonder why contracts stall for 12–18 months.

They are optimizing the wrong layer.

Where the Calculator Fits In

This is exactly why I built the US VBC + Funding Master Stack Diagnostic.

The tool forces you to answer uncomfortable questions:

• How strong is your CPT alignment?

• Is your PMPM ROI credible?

• Is your RWE validated in claims data?

• Is your risk-share structure defensible?

• What is your dilution impact if contracts delay?

• How long is your runway under current burn?

Most founders cannot quantify these simultaneously.

The calculator models:

📊 Contract Readiness Score
💰 Dilution Impact
⏳ Runway After Non-Dilutive
🏥 MA Viability Gate
📈 Combined Fundability × Contractability

It reveals whether you are:

• Pilot-ready

• Negotiation-ready

• Or MA-scale ready

And more importantly:

It shows investors what they are underwriting.

Conversion Logic: Why This Matters for Founders

If your VBC readiness is weak:

• Contracts delay

• Sales cycles extend

• Burn increases

• Dilution worsens

• Negotiating leverage declines

If your VBC architecture is strong:

• Time-to-close shortens

• Savings confidence increases

• MA plans engage economically

• Shared savings become viable

• Valuation compression risk decreases

Commercialization strength directly impacts capital efficiency.

This is not branding.

It is structural.

The Missing Link

You do not need more outbound emails.

You do not need another pilot.

You need:

• A coding strategy map

• An MA alignment model

• A claims-based ROI calculator

• A risk-adjusted revenue framework

• A shared-savings negotiation playbook

• A funding stack optimized around contract velocity

That is the layer I build inside GrowthVybz.

Not pitch decks.

Infrastructure.

Because the difference between:

Pilot-stage digital health
and
Risk-aligned healthcare infrastructure

is architectural, not technological.